Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Aug 26, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.9M
Net Open-Market Flow
-$4.9M
Transactions
8
7 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2026Option exercise(M)10K$135.42$1.3M334K
Aug 25, 2026Sell(S)2K$516.12$1.0M332K
Aug 25, 2026Sell(S)2K$516.95$1.2M330K
Aug 25, 2026Sell(S)2K$518.08$1.0M328K
Aug 25, 2026Sell(S)2K$518.80$1.2M325K
Aug 25, 2026Sell(S)668$519.91$347K325K
Aug 25, 2026Sell(S)80$520.50$42K324K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2026Option exercise(M)10K$066K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000128) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.